home / stock / jnj / jnj news


JNJ News and Press, Johnson & Johnson

Stock Information

Company Name: Johnson & Johnson
Stock Symbol: JNJ
Market: NYSE
Website: jnj.com

Menu

JNJ JNJ Quote JNJ Short JNJ News JNJ Articles JNJ Message Board
Get JNJ Alerts

News, Short Squeeze, Breakout and More Instantly...

JNJ - Regeneron: Fairly Valued Now After A Stellar Upswing

2026-03-11 09:47:27 ET Regeneron Pharmaceuticals, Inc. ( REGN ) is a well-established biotech company based in Tarrytown, NY, that has had a phenomenal journey since its founding in 1988, but most clearly – for shareholders – since it reached an inflection point in 201...

JNJ - Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity

2026-03-11 09:36:00 ET ... Read the full article on Seeking Alpha For further details see: Goldman Sachs Large Cap Equity Fund Q4 2025 Portfolio Activity

JNJ - Johnson & Johnson (JNJ) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

2026-03-10 17:10:15 ET Johnson & Johnson (JNJ) Barclays 28th Annual Global Healthcare Conference March 10, 2026 11:30 AM EDT... Read the full article on Seeking Alpha For further details see: Johnson & Johnson (JNJ) Presents at Barclays 28th Annual Global Healthcare ...

JNJ - Dow Jones Industrial Average Monitor Update: A Look At 30 U.S. Large-Caps

2026-03-10 05:26:00 ET Looking at the direction of Visible Alpha consensus, post-earnings season of the thirty companies in the Dow Jones Industrial Average ( DJIA ) , the data points to the potential for further surprises. The macroeconomic and sector-specific issues vary signi...

JNJ - Neuropsychiatric Innovation Draws Big Pharma Interest and Fresh Investment

Issued on behalf of Cybin D/B/A Helus Pharma VANCOUVER — Baystreet.ca News Commentary — The convergence of precision medicine, novel mechanisms, and regulatory support is driving a renaissance in neuropsychiatric drug development 1 . Federal production quotas for c...

JNJ - FDA plans to relax testing rules to encourage biosimilar drugs: report

2026-03-09 06:44:09 ET The U.S. Food and Drug Administration is reportedly easing some requirements for drugmakers developing copycat versions of costly biologic medications in a bid to bring more competition to the market and lower costs. The agency plans to reduce the need f...

JNJ - 2 No-Brainer Dividend Stocks to Buy in 2026

2026-03-08 12:47:00 ET Dividend stocks are not all the same. Some will readily decrease or suspend their payouts at the first sign of trouble, while others will continue increasing them even during market downturns or economic recessions. Dividend investors prefer those that are in the ...

JNJ - These 7 Elite Dividend Stocks Pay $114 Billion Annually, Combined, to Their Shareholders

2026-03-08 12:26:00 ET There are countless ways for investors to make money on Wall Street, but few are as consistently successful as buying and holding high-quality dividend stocks. Based on a study by Hartford Funds, in collaboration with Ned Davis Research ("The Power of Dividends: Past,...

JNJ - FDA vaccine chief to leave the agency again

2026-03-07 07:41:45 ET More on Pfizer, Johnson & Johnson, etc. Pfizer: Obesity Hype And Vaccine Policy Shocks The Sun Will Shine On Moderna Again - Initiating With A Buy Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom J&J subsidi...

JNJ - Dividend Champion, Contender, And Challenger Highlights: Week Of March 8

2026-03-06 18:03:48 ET Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts. However, since this list is only produced once per month, the data in it can quickly get out of date. Furthermore, w...

Next 10